Results 211 to 220 of about 264,021 (301)

Expert Consensus on the Standardized Diagnosis, Treatment, and Management of Cancer in High‐Altitude Regions of China

open access: yesCancer Innovation, Volume 5, Issue 5, October 2026.
This expert consensus establishes standardized diagnostic, therapeutic, and management frameworks for cancers in high‐altitude regions of China, addressing epidemiological characteristics, tailored treatments, and highland‐specific adverse events to optimize care for plateau populations.
Yiqun Li   +49 more
wiley   +1 more source

Postoperative radiotherapy in patients with R0 resection of soft tissue sarcoma: results from the European sarcoma CONTICABASE analysis. [PDF]

open access: yesBr J Radiol
Sunyach MP   +16 more
europepmc   +1 more source

R0 and yR0 resections for colorectal liver metastases: need for a precise definition

open access: yesInternational Journal of Colorectal Disease, 2016
Sotiropoulos, G.C.   +2 more
openaire   +3 more sources

Five‐Year Survival Analyses on Non‐Pathological Complete Response Esophageal Squamous Cell Carcinoma Patients After Neoadjuvant Regimens Plus Surgery: A Propensity Score Matching, Real‐World Cohort Study

open access: yesCancer Medicine, Volume 15, Issue 10, October 2026.
ABSTRACT Background Non‐pathological complete response (non‐pCR) is common in esophageal squamous cell carcinoma (ESCC) patients after neoadjuvant therapy, yet evidence guiding long‐term outcomes and postoperative risk stratification in the immunotherapy era remains limited.
Weibin Liu   +9 more
wiley   +1 more source

Head & Neck and Shoulder Desmoid‐Type Fibromatosis: Presentation and Natural History of These Ultra‐Rare Locations

open access: yesCancer Medicine, Volume 15, Issue 10, October 2026.
ABSTRACT Background Active surveillance is recommended as the first‐line management for desmoid‐type fibromatosis (DF); however, data on DF of the head and neck (H&N) and shoulder regions are limited. Methods We examined patients with DF located in the H&N and shoulder regions, comparing baseline characteristics and event‐free survival (EFS).
Nicolas Penel   +19 more
wiley   +1 more source

PD‐1 Inhibitor (Sintilimab) Combined With Chemotherapy as Neoadjuvant Therapy in Advanced Ovarian Cancer: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 10, October 2026.
ABSTRACT In a patient with advanced ovarian cancer showing limited response to paclitaxel–carboplatin, adding sintilimab was associated with R0 cytoreduction and sustained disease‐free status during olaparib–bevacizumab maintenance. This case provides a rationale for further investigation of PD‐1 blockade as neoadjuvant therapy in carefully selected ...
Wang Zhenyan, Wang Yan
wiley   +1 more source

Preoperative Arterial Embolization Facilitating Safe Resection of a Hypervascular Aggressive Angiomyxoma: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 10, October 2026.
ABSTRACT A 22‐year‐old woman presented with a 12‐cm hypervascular aggressive angiomyxoma. Difficult hemostasis during biopsy prompted preoperative selective arterial embolization followed by complete macroscopic resection with only 50 mL of blood loss.
Yukako Takashima   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy